SARS-CoV-2 - Azithromycin - Therapeutic Candidates

SARS-CoV-2 - Azithromycin - Therapeutic Candidates


Azithromycin is a macrolide antibiotic. This broad-spectrum antibiotic of the azalide group is a derivative of erythromycin. Azithromycin is indicated for the treatment of certain types of mild to moderate infections caused by bacteria. Most commonly, it is used to treat ear infections such as otitis media, throat and lung infections such as pharyngitis and pneumonia, and certain skin infections. Azithromycin is also prescribed to patients with cystic fibrosis because they are particularly susceptible to respiratory infections.
A recent study, in the context of the Covid-19 epidemic currently affecting many countries around the world, sought to investigate the effect of azithromycin in combination with hydroxychloroquine. The interest in azithromycin came from the fact that the rate of Covid-19 infection was low in a large cohort of patients with cystic fibrosis, many of whom are on azithromycin therapy.

Ergebnis Ihrer Suche : 238 Produkt(e) gefunden

Grenzen Sie Ihre Suche ein :

RUOCE / IVD
  • Unconjugated 38
  • [14C] 1
  • [3H] 1
  • Biochemicals 192
  • Inhibitor/Antagonist/Agonist 40
  • Buffers and reagents 2
  • Radiochemicals 2
  • cell culture products 2
  • Assay 3
  • Cell culture 2
FILTER ANWENDEN
REINITIALISIEREN


Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
NB-42-00091-5g
 5g 
NB-42-00091-1g
 1g 
NB-48-0175-500MG
 500mg 
B1398-50mg
 50mg 
T6401-100mg
 100mg 
T6401-1mL
 1mL 
T6401-200mg
 200mg 
T6401-50mg
 50mg 
T6401-500mg
 500mg 
HY-17506-1ml
 10mM/1mL 
HY-17506-50mg
 50mg 
HY-17506-100mg
 100mg 
331-20216-2
 25mg 
331-20216-1
 10mM(in1mLDMSO) 
331-20216-3
 50mg 
AG003NY3-1g
 1g 
407380-1mg
 1mg 
407380-2.5mg
 2.5mg